Consultation on applications for authorisation of 3 CBD food products as novel foods

Applies to England, Northern Ireland and Wales

The Food Standards Agency response addresses questions regarding labelling, the acceptable daily intake, food supplements, consumer misperception, vulnerable groups and under-18s, legal status, enforcement, the public list and data protection.

The Food Standards Agency received a total of 46 responses.

38 of the responses were received through the consultation form, and the remaining 8 were received via email. 

19 of the responses were from individuals and 27 were from organisations and included local authorities, CBD industry, and applicants and trade associations.

This consultation seeks stakeholders’ views, comments and feedback in relation to 3 regulated product applications. The applications are for authorisation of “synthetic cannabidiol (CBD)”, “cannabidiol (CBD) isolate” and “isolated cannabidiol (CBD) derived from hemp (Cannabis sativa)” as novel foods.

This consultation was held on another website.

This consultation ran from
28 August 2025 to 11:59pm on 19 November 2025

This consultation seeks stakeholders’ views, comments and feedback in relation to 3 regulated product applications.

The applications are for authorisation of “synthetic cannabidiol (CBD)”, “cannabidiol (CBD) isolate” and “isolated cannabidiol (CBD) derived from hemp (Cannabis sativa)” as novel foods. The FSA will consider stakeholder responses before preparing final advice to ministers in England and Wales, with the Minister for Health in Northern Ireland kept informed. The determination on authorisation sits with ministers; the Food Standards Agency (FSA) has prepared draft recommendations for each application, which are included in the consultation. The draft recommendations are to authorise the 3 novel foods, subject to meeting the terms of authorisation that are set out in the consultation.